Upstream Bio Stock (NASDAQ: UPB) stock price, news, charts, stock research, profile.
You can purchase shares of Upstream Bio (NASDAQ:UPB) through any online brokerage.
Other companies in Upstream Bio’s space includes: 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL) and Arcutis Biotherapeutics (NASDAQ:ARQT).
Upstream Bio has a consensus price target of $56.50.
The stock price for Upstream Bio (NASDAQ: UPB) is $18.69 last updated November 25, 2024 at 4:00 PM EST.
There are no upcoming dividends for Upstream Bio.
Upstream Bio’s Q4 earnings are confirmed for Friday, February 14, 2025.
There is no upcoming split for Upstream Bio.
Upstream Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.